Edesa Biotech Inc <EDSA.OQ> expected to post a loss of 29 cents a share - Earnings Preview

• Edesa Biotech Inc EDSA.OQ EDSA.O is expected to show no change in quarterly revenue when it reports results on May 8 (estimated) for the period ending March 31 2025

• ​LSEG's mean analyst estimate for Edesa Biotech Inc is for a loss of 29 cents per share.

• The one available analyst rating on the shares is "buy".

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for Edesa Biotech Inc is $19.00​, above​ its last closing price of $2.40. ​​​

This summary was machine generated May 6 at 21:28 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)